Runs a 700-bed JCI-accredited hospital in Gurugram; expanding to Raipur, South Delhi and Mauritius.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 16 |
| Reserves | 300 | 307 | 346 | 390 | 435 | 824 | 873 | 919 |
| Borrowings | 113 | 147 | 201 | 286 | 320 | 290 | 274 | 262 |
| Other Liabilities | 160 | 133 | 149 | 216 | 203 | 229 | 255 | 232 |
| Total Liabilities | 586 | 600 | 710 | 905 | 972 | 1.4k | 1.4k | 1.4k |
| AssetsFixed Assets | 393 | 383 | 489 | 605 | 719 | 745 | 780 | 804 |
| CWIP | 56 | 81 | 64 | 95 | 33 | 40 | 37 | 29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 |
| Other Assets | 137 | 136 | 157 | 205 | 219 | 572 | 584 | 596 |
| Total Assets | 586 | 600 | 710 | 905 | 972 | 1.4k | 1.4k | 1.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 40 | 56 | 27 | 60 | 127 | 109 | 156 | 132 |
| Cash from Investing | -50 | -26 | -37 | -107 | -158 | -88 | -393 | -90 |
| Cash from Financing | 14 | -27 | 18 | 44 | 38 | -29 | 264 | -50 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -17 | 30 | -4 | -49 | -18 | 37 | 65 | 32 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (44.9×) and current (36.9×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 35.9% growth and a 37× exit, ₹259 only delivers your return if you pay ₹579. The price is currently baking in 18% growth.
EPS grows 35.9%/yr for 5 years, then fades to 6% over 2, exits at 37×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 35.9% | 9.51 |
| FY28 | 35.9% | 12.93 |
| FY29 | 35.9% | 17.57 |
| FY30 | 35.9% | 23.88 |
| FY31 | 35.9% | 32.45 |
| FY32 | 20.9% ·fade | 39.25 |
| FY33 | 6.0% ·fade | 41.60 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.